Affect Therapeutics was founded with the mission to revolutionize addiction treatment through digital means. The company offers an integrated digital treatment program for drug and alcohol addiction via a mobile app. Their core vision is to make effective addiction treatment accessible and engaging by leveraging technology. The program addresses various substance use disorders and incorporates financial incentives to encourage users to adopt healthy behaviors and develop new habits. Their market focus is primarily on individuals seeking convenient and supportive addiction treatment solutions.
Notable affiliated people and investors include experts in addiction treatment and digital health, though specific names are not provided. Affect Therapeutics has achieved significant milestones in demonstrating the efficacy of their digital approach to addiction treatment. The overall impact of Affect Therapeutics lies in its innovative use of technology to provide accessible, supportive, and effective treatment options for individuals struggling with addiction, thereby contributing to improved public health outcomes.